Press release
North America and Europe PEGylated Drugs Market Set for Rapid Growth | Key Players: Shire Group, UCB, Merck, AstraZeneca, Amgen, Sigma Tau
North America and Europe PEGylated Drugs Market
Increasing R&D investment of biotechnology & pharmaceutical companies to develop enhanced PEGylated drugs for treatment of various chronic diseases along with rising occurrence of chronic ailments in developed regions will propel PEGylated drugs market growth over the forecast period.
Major advancements in biologics sector including advances in drug antibody conjugates, and immunotherapies will positively impact market growth. Moreover, rising incidences of chronic ailments and increasing death rates associated with cancer in Canada will propel industry growth. However, the side-effects associated with pegylated drugs along with drug failure will impede PEGylated drugs market growth over the forecast timeframe.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2511
Browse key industry insights spread across 120 pages with 31 market data tables & 8 figures & charts from the report, “North America and Europe PEGylated Drugs Market Size, By Disease Indication (Cancer, Hepatitis, Multiple Sclerosis, Gastrointestinal Disorders), By Type (Monoclonal antibodies, Colony Stimulating Factors, Interferons), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy) Application Development, Competitive Landscape & Forecast, 2018 – 2024” in detail along with the table of contents.
Cancer segment held over 60% of the overall market share in 2017 due to growing prevalence of the disease creating a demand for the development of effective drugs. Benefits offered by PEGylated drugs such as reduced proteolytic degradation along with minimized immunogenicity leading to enhanced therapeutic efficacy will propel market growth. Increasing areas of applications as well as rising adoption of PEGylated drugs to treat various types of cancer will stimulate business growth.
Hepatitis segment size was USD 156 million in 2017 and is anticipated to follow a declining trend over the forecast period. However, increasing focus of industry players to develop pegylated drugs used for the treatment of such chronic conditions will contribute to market growth. For instance, launch of Pegasys drug used for treating Hepatitis C in adult patients will fuel market growth.
Monoclonal antibodies are anticipated to witness over 12% CAGR over the coming years due to its wide-ranging applications such as, anti-PEG antibodies are used to quantitate numerous PEGylated compounds. Additionally, anti-PEG antibodies can be combined with compound specific to antibody to generate specific and sensitive assays.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2511
Canada PEGylated drugs market will witness over 5.5% CAGR from 2018 to 2024. Increasing prevalence of chronic ailments such as cancer will drive the business growth. As per Canadian Cancer Society, more than two lac people are diagnosed with cancer in 2017 that will surge demand for pegylated drugs in the future. Development and availability of various pegylated drugs including Onivyde, Plegridy, Oncaspar and others for treatment of several chronic ailments are factors accelerating business growth over the forecast timeframe.
Italy PEGylated drugs market was USD 218 million in 2017 and is anticipated to witness 9% CAGR over the coming few years. Increasing usage of peg-interferons for the treatment of Hepatitis C and soaring adoption of PEG-IFN beta-1a injectables for the treatment of patients with multiple sclerosis will foster market growth.
Few notable industry players operating in North America and Europe PEGylated drugs market are Shire Group, UCB, Merck, AstraZeneca, Amgen, Sigma Tau, Biogen, Pfizer and Roche. Industry players attempt to develop enhanced and effective PEGylated drugs for treating chronic conditions. Robust pipeline and ongoing research studies coupled with high R&D investment in PEGylation technology is anticipated to propel industry growth.
lobal Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development
Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North America and Europe PEGylated Drugs Market Set for Rapid Growth | Key Players: Shire Group, UCB, Merck, AstraZeneca, Amgen, Sigma Tau here
News-ID: 1216856 • Views: …
More Releases from Global Market Insights Inc.
Latest Research Report On Agricultural Adjuvants Market 2021. Major Players Incl …
The agricultural adjuvants market is expected to observe noteworthy growth on account of increasing demand for high-quality crops. Adjuvants commonly act as an additive in pesticides that increase its effectiveness and smoothen its mixing application.
The demand for plant protection products in countries like Bangladesh, India, and Vietnam has surged considerably in recent years. Ever-increasing population across developing economies has forced farmers to produce large quantities of high-quality yields. Citing…
U.S. Minoxidil Market 2021 Growth Opportunities and Competitive Landscape 2027 - …
The U.S. minoxidil industry has been impacted by the COVID-19 pandemic in the form of increased stress amid job losses and health issues, creating rising incidences of hair fall and associated problems. The industry is expected to gain commendable proceeds on account of an upsurge in research studies concerned with the effectiveness of minoxidil.
Citing one such instance, in January 2021, a study published in the Dermatologic Therapy supported the efficacy…
Global Sulfosuccinate Market 2021 Future Growth With Technology and Current Tren …
Owing to these factors, estimates have revealed that the global sulfosuccinate market size will exceed USD 475.7 million in annual estimation by 2024.
Increasing adoption of high-performance materials that meet application-specific requirements across various industries, including pharmaceuticals will stimulate the need for sulfosuccinate compounds. The surging disposable incomes of consumers mainly across the developing nations have also fueled their spending capacities on household and personal care.
Sulfosuccinates are mainly a mild type…
By 2026, Graphene Market will register over 35% CAGR | Applied Nanotech, Inc, an …
The global Graphene Market is slated to gain significant momentum over the forthcoming years, as a result of the growing product consumption in the electronics sector, particularly in developing countries. This high consumption can be attributed to its superior qualities such as high electrical conductivity, durability, and toughness.
Request a sample of this research report @
https://www.gminsights.com/request-sample/detail/233
Top Key Players in The Market are:
Graphenea S.A., Applied Graphene Materials plc, ACS…
More Releases for PEGylated
Rising Prevalence Of Lifestyle Diseases Is Driving Growth Of The PEGylated Prote …
The PEGylated Proteins Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the PEGylated Proteins Market Size and Projected Growth Rate?
The pegylated proteins market, valued at $1.47 billion in 2024, is expected to grow to $1.68 billion in 2025, with a CAGR of 14.1%.…
PEGylated Proteins Market Size: Strong Growth Ahead (2025-2032)
Latest Market Overview
The global PEGylated proteins market is witnessing significant growth, driven by an expanding range of therapeutic applications and increasing demand for protein-based drugs. In 2024, the PEGylated proteins market is estimated to be valued at USD 7.5 billion, with forecasts projecting a robust growth trajectory through 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 8.2% during the forecast period. The rising…
PEGylated Proteins Market to Witness Robust Expansion by 2024
Market Research Report Store offers a latest published report on PEGylated Proteins Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the PEGylated Proteins market will register a 3.9% CAGR in terms of revenue, the global market size will reach US$ 3819.7 million by 2024, from US$ 3275 million in 2019. In…
PEGylated Proteins Market - Competitive Landscape and Key Product Segments
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in…
PEGylated Proteins Market: Competitive Dynamics & Global Outlook 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global PEGylated Proteins market.
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.
Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/2882/global-pegylated-proteins-market
Global PEGylated Proteins Market: Forecast by…
PEGylated Proteins 2024 Market Research Report
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in…
